Last reviewed · How we verify
NCT01594632
A Study to Evaluate the Contraceptive Effectiveness, Safety and Acceptability of Sino-implant II
NA trial testing Jadelle in Contraception in 650 participants. Completed in 4 July 2017.
4 July 2017
Quick facts
| Lead sponsor | FHI 360 |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 650 |
| Start date | 1 January 2011 |
| Primary completion | 4 July 2017 |
| Estimated completion | 4 July 2017 |
| Sites | 1 location across Dominican Republic |
Drugs / interventions tested
- Jadelle (LEVONORGESTREL) — full drug profile →
- Sino-implant (II) — full drug profile →
Conditions studied
- Contraception — all drugs for Contraception →
Sponsor
FHI 360 — full company profile →
Who can join
Adults 18 to 44, female only, with Contraception. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Evaluate the contraceptive effectiveness of Sino-implant (II) during 4 years of use.
Time frame: 4 years
Pearl Index (number of pregnancies per 100 woman-years) over 4 years of use of Sino-implant (II).
Sponsor's own description
A study to assess the contraceptive effectiveness of Sino-implant (II).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01594632
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Contraception
Currently open trials in the same condition.
- NCT07365904 — Investigating Ovulation Inhibition for Use as a Contraceptive · Phase 2 · recruiting
- NCT07437495 — Women's Knowledge of Contraception During the Postpartum Period · active not recruiting
- NCT06823037 — Hormonal Contraception Access Through Pharmacist Prescribing Implementation · NA · recruiting
- NCT07326007 — Verbal Analgesia Versus Standard Technique for Pain Control During Copper T380A Intrauterine Device Insertion in Women W · NA · recruiting
- NCT05910580 — Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years · NA · recruiting
Other FHI 360 trials
Trials by the same sponsor.
- NCT05233956 — Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya · NA · active not recruiting
- NCT05937698 — The CATALYST Study · terminated
- NCT05889533 — Eswatini Ring Study: Increasing PrEP Options for Women · terminated
- NCT05016895 — REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire · NA · completed
- NCT04617626 — Resiliency Through Azithromycin for Children (REACH), Côte d'Ivoire · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01594632 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by FHI 360
- Last refreshed: 19 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01594632.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing